⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVO News
CervoMed Inc. Common Stock
Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum
globenewswire.com
NTHI
CRVO
EWTX
Form 8-K
sec.gov
CRVO
CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies
globenewswire.com
CRVO